Literature DB >> 9816038

Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.

J A Houghton1, D M Tillman, F G Harwood.   

Abstract

In colon cancers induction of a thymineless state following inhibition of thymidylate synthase (TS) by 5-fluorouracil combined with leucovorin can initiate a cytotoxic response. Using a 5-fluorouracil-leucovorin-treated human colon carcinoma cell line (GC3/cl) and a clonally derived TS- mutant, initiation events that dictate the onset of and commitment to thymineless death have been examined. Initial events related to a temporally associated decrease in dTTP and elevation in the dATP pools; no depletion of dGTP or elevation in dCTP was detected. Nucleosomal degradation of DNA commenced at 24 h in TS- and 49 h in GC3/c1, and was associated with the more rapid development of an imbalance in the dATP and dTTP pools and a higher dATP:dTTP ratio in TS- cells. The contribution of elevated dATP or depleted dTTP pools to thymineless death was subsequently determined by treatment of GC3/cl or TS- cells with deoxyadenosine to elevate the dATP pool either under thymidine-replete or thymineless conditions. Thus, deoxyadenosine supplementation under dTTP-replete conditions elevated the dATP pool for 16 h and was cytotoxic to cells. During dTTP depletion elevated dATP was maintained, and cytotoxicity was significantly and rapidly enhanced by deoxyadenosine but could be reversed by thymidine. Data suggest that maintenance of elevated dATP and the dATP:dTTP ratio are essential initiation events in the commitment of colon carcinoma cells to thymineless death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9816038

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  28 in total

1.  Thymineless death in colon carcinoma cells is mediated via fas signaling.

Authors:  J A Houghton; F G Harwood; D M Tillman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches.

Authors:  Sheryl A Flanagan; Christina M Krokosky; Sudha Mannava; Mikhail A Nikiforov; Donna S Shewach
Journal:  Mol Pharmacol       Date:  2008-06-05       Impact factor: 4.436

Review 3.  Uracil in DNA: consequences for carcinogenesis and chemotherapy.

Authors:  Sondra H Berger; Douglas L Pittman; Michael D Wyatt
Journal:  Biochem Pharmacol       Date:  2008-07-01       Impact factor: 5.858

4.  Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.

Authors:  Breeana C Grogan; Jared B Parker; Amy F Guminski; James T Stivers
Journal:  Biochemistry       Date:  2011-01-11       Impact factor: 3.162

5.  Nucleolar localization of the Notch4 intracellular domain underpins its regulation of the cellular response to genotoxic stressors.

Authors:  Neetu Saini; Apurva Sarin
Journal:  Cell Death Discov       Date:  2020-02-18

6.  Cytochrome oxidase deficiency protects Escherichia coli from cell death but not from filamentation due to thymine deficiency or DNA polymerase inactivation.

Authors:  Bernard Strauss; Kemba Kelly; Damian Ekiert
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 7.  Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?

Authors:  Valentina Fodale; Mariaelena Pierobon; Lance Liotta; Emanuel Petricoin
Journal:  Cancer J       Date:  2011 Mar-Apr       Impact factor: 3.360

8.  Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.

Authors:  Ofonime Udofot; Kevin Affram; Taylor Smith; Bulumko Tshabe; Sunil Krishnan; Mandip Sachdeva; Edward Agyare
Journal:  J Nat Sci       Date:  2016

9.  Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.

Authors:  Yuhong Luo; Mike Walla; Michael D Wyatt
Journal:  DNA Repair (Amst)       Date:  2007-10-17

10.  Induction of intrachromosomal homologous recombination in human cells by raltitrexed, an inhibitor of thymidylate synthase.

Authors:  Barbara Criscuolo Waldman; Yibin Wang; Kasturi Kilaru; Zhengguan Yang; Alaukik Bhasin; Michael D Wyatt; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2008-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.